Zhang, Hailong
Zheng, Yajuan
Pan, Youdong
Lin, Changdong
Wang, Shihui
Yan, Zhanjun
Lu, Ling
Ge, Gaoxiang
Li, Jinsong
Zeng, Yi Arial
Chen, Jianfeng
Funding for this research was provided by:
National Natural Science Foundation of China (31525016, 31830112, 31271487)
Personalized Medicines-Molecular Signature-based Drug Discovery and Development, the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010101)
Program of Shanghai Academic Research Leader (19XD1404200)
National Ten Thousand Talents Program (No)
SA-SIBS Scholarship Program (No)
Article History
Received: 6 January 2020
Accepted: 21 April 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: The research of mouse experiments in the manuscript has been conducted under the guidance of international ethical standards. All research protocols were conducted with the approval of the Institutional Animal Care and Use Committee of the Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science.
: Not applicable.
: The authors declare that they have no competing interests.